M. Saleem Ismail
| Title | Clinical Associate Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Psychiatry |
|---|
| Address | Monroe Community Hospital 435 E. Henrietta Road Rochester NY 14620
|
|---|
|
|
|
| 1983 |
|
| Pakistan Veraval Memon Anjuman Award | | 1995 |
|
| U.S. Psychiatric Congress | Eli Lilly Fellow | | 1995 |
|
| The National Institute of Mental Health Ninth Annual Summer Research | NIMH | | 2003 |
|
| Institute Geriatric Psychiatry-Fellow |
-
Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Arch Neurol. 2008 Jul; 65(7):896-905.
-
Ismail MS, Dagerman K, Tariot PN, Abbott S, Kavanagh S, Schneider LS. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness- Alzheimer's Disease (CATIE-AD): baseline characteristics. Curr Alzheimer Res. 2007 Jul; 4(3):325-35.
-
Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT). PLoS Clin Trials. 2006; 1(7):e33.
-
Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, Lebowitz BD, Lyketsos CG, Ryan JM, Stroup TS, Sultzer DL, Weintraub D, Lieberman JA. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med. 2006 Oct 12; 355(15):1525-38.
-
Ismail MS. Long-term benefits of early pharmacologic treatment in Alzheimer's disease. Interview by Frederic Flach. Essent Psychopharmacol. 2005; 6(4):227-37.
-
Ismail MS, Richard IH. A reality test: How well do we understand psychosis in Parkinson's disease? J Neuropsychiatry Clin Neurosci. 2004; 16(1):8-18.
-
Tariot PN, Profenno LA, Ismail MS. Efficacy of atypical antipsychotics in elderly patients with dementia. J Clin Psychiatry. 2004; 65 Suppl 11:11-5.
-
Schneider LS, Ismail MS, Dagerman K, Davis S, Olin J, McManus D, Pfeiffer E, Ryan JM, Sultzer DL, Tariot PN. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial. Schizophr Bull. 2003; 29(1):57-72.
-
Tariot PN, Loy R, Ryan JM, Porsteinsson A, Ismail S. Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales. Adv Drug Deliv Rev. 2002 Dec 7; 54(12):1567-77.
-
Tariot PN, Ismail MS. Use of quetiapine in elderly patients. J Clin Psychiatry. 2002; 63 Suppl 13:21-6.
|
Ismail's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|